{"filing":{"accession_number":"0001213900-26-065392","cik":"0001840317","ticker":"VEEAW","company_name":"VEEA INC.","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"ea0293670-8k_veea.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1840317/000121390026065392/ea0293670-8k_veea.htm"},"events":[{"id":6863,"run_id":6012,"accession_number":"0001213900-26-065392","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"The filing discloses that following the death of director Douglas Maine on June 1, 2026, the Company notified Nasdaq on June 2, 2026 that it is no longer in compliance with three critical Nasdaq Listing Rules: the majority independent director requirement (Rule 5605(b)(1)), the audit committee independence requirement (Rule 5605(c)(2)(A)), and the compensation committee independence requirement (Rule 5605(d)(2)(A)). Although Nasdaq has granted a cure period until the earlier of the next Annual Meeting or May 31, 2027, the filing explicitly states \"there can be no assurance that Company will be able to regain compliance with the applicable Nasdaq Listing Rules\" within the required timeframe, creating material delisting risk.","company_name":"VEEA INC.","ticker":"VEEAW","filing_date":"2026-06-04","submitted_at":null,"items":[{"id":4401,"accession_number":"0001213900-26-065392","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that following the death of director Douglas Maine on June 1, 2026, the Company notified Nasdaq on June 2, 2026 that it is no longer in compliance with three critical Nasdaq Listing Rules: the majority independent director requirement (Rule 5605(b)(1)), the audit committee independence requirement (Rule 5605(c)(2)(A)), and the compensation committee independence requirement (Rule 5605(d)(2)(A)). Although Nasdaq has granted a cure period until the earlier of the next Annual Meeting or May 31, 2027, the filing explicitly states \"there can be no assurance that Company will be able to regain compliance with the applicable Nasdaq Listing Rules\" within the required timeframe, creating material delisting risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:17:34.071227+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4401,"accession_number":"0001213900-26-065392","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that following the death of director Douglas Maine on June 1, 2026, the Company notified Nasdaq on June 2, 2026 that it is no longer in compliance with three critical Nasdaq Listing Rules: the majority independent director requirement (Rule 5605(b)(1)), the audit committee independence requirement (Rule 5605(c)(2)(A)), and the compensation committee independence requirement (Rule 5605(d)(2)(A)). Although Nasdaq has granted a cure period until the earlier of the next Annual Meeting or May 31, 2027, the filing explicitly states \"there can be no assurance that Company will be able to regain compliance with the applicable Nasdaq Listing Rules\" within the required timeframe, creating material delisting risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:17:34.071227+00:00","company_name":"VEEA INC.","ticker":"VEEAW","filing_date":"2026-06-04"}]}